Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
MERS-CoV 감염의 붉은털 원숭이 모델에서 예방 및 치료 렘데시비르(GS-5734) 치료
530
Published on
Journal: Proceedings of the National Academy of Sciences of [Category] MERS, SARS, 비임상,
Journal: Proceedings of the National Academy of Sciences of [Category] MERS, SARS, 비임상,
[키워드] 2019-nCoV
acute respiratory syndrome
Administered
animal model
animals
Antiviral
Antiviral treatment
antiviral treatments
breath
Case fatality rate
caused
clinical benefit
clinical disease
Clinical signs
clinical trial
clinical trials
coronavirus
Coronaviruses
CoV infection
damage
effective
Efficacy
Fatality rate
GS-5734
implementation
in vitro
inhibited
initiated
inoculation
lung
lung lesions
Lungs
MERS
MERS coronavirus
MERS-CoV
MERS-CoV infection
Middle East
Middle East respiratory syndrome
mouse model
nCoV
Novel coronavirus
prevented
Prophylactic
provided
reduced
reduction in
Remdesivir
Replication
respiratory
Respiratory disease
respiratory tissues
rhesus
rhesus macaque
Severe acute respiratory syndrome
severe respiratory disease
severity
Severity of disease
shown
Significance
Support
tested
therapeutic
therapy
Treatment
utility
virus replication
were infected
Wuhan
Wuhan, China
[DOI] 10.1073/pnas.1922083117 PMC 바로가기 [Article Type] 530
[DOI] 10.1073/pnas.1922083117 PMC 바로가기 [Article Type] 530